- Filed
- Oct 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Oct 9, 2025 | 66.03M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 29.76M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 23.5M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $52.17K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $727 |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$251.15K |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$51.75K |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2023 | $126.68K |
| Stockholders Equity restated | Q1 2024 · Dec 31, 2022 | −$1.06M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $345.88K |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $263.21K |
| Current Assets | Q1 2024 · Mar 31, 2024 | $94.72K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $211.46K |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.01 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$188.85K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | $0 |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $24.75K |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $0 |
| Revenue | Q1 2024 · Mar 31, 2024 | $35.06K |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $0 |